(Q38717360)
Statements
TMEM16A/ANO1 suppression improves response to antibody-mediated targeted therapy of EGFR and HER2/ERBB2. (English)
1 reference
Jennifer R Grandis
1 reference
Sucheta Kulkarni
1 reference
Anke Bill
1 reference
Neal R Godse
1 reference
Nayel I Khan
1 reference
Jason I Kass
1 reference
Kevin Steehler
1 reference
Carolyn Kemp
1 reference
Kara Davis
1 reference
Carol A Bertrand
1 reference
Avani R Vyas
1 reference
Douglas E Holt
1 reference
L Alex Gaither
1 reference
Umamaheswar Duvvuri
1 reference
3 April 2017
1 reference
56
1 reference
6
1 reference
460-471
1 reference
1 reference
1 reference
1 reference
1 reference
Identifiers
1 reference